Respiratory Devices Market, by Product Type (Therapeutic Devices, Diagnostic Devices, Monitoring Devices and Consumables, and Accessories), by Age Group (Neonatal/ Pediatric and Adults), by Application (COPD, Sleep Apnea, Asthma, and Others), by End User (Hospitals, Clinics, Home Care Settings, and Ambulatory Care Settings) and by Region - Global Trends and forecast till 2025

  • Published On : Feb 2018 |
  • Pages : 205 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Respiratory Devices Market – Breathing Life into Critically ill Patients

Respiratory devices help to remove mucus from the airways and improve pulmonary function. These devices increase compliance of patients suffering from respiratory diseases to daily treatment. Some of the these devices include, positive expiratory pressure, the high frequency chest wall oscillation, the oral high frequency oscillation, the intrapulmonary percussive ventilation, the incentive spirometry the flutter and the acapella and the cornet. These devices automatically adjust inhalations and exhalations according to the patient’s requirement. The devices are also available in various versions such as emergency respiratory devices for rescue application, long-term respiratory devices for intensive care, and mobile home respiratory devices.

The global respiratory devices market was valued at US$ 15,143.2 million in 2016 and is expected to witness a robust CAGR of 8.8% over the forecast period (2017 - 2025).

Figure 1. Global Respiratory Devices Market (US$ Mn), by Region, 2016

respiratory devices market

Source: Coherent Market Insights (2018)

Increasing admissions of critical care patients in Intensive Care Units (ICU) is expected to fuel the market growth

Increasing prevalence of chronic respiratory diseases such as asthma, chronic pulmonary lung disease, pulmonary hypertension, and occupational lung disease are the major factors augmenting growth of the respiratory devices market, owing to the pronounced need of therapeutic respiratory devices in the medical as well as in the homecare settings. According to the World Health Organization (WHO), in 2017, asthma is a major non communicable disease with an estimated 235 million people suffering from the condition. According to the American Academy of Allergy Asthma and Immunology, 2015, an estimated number of people suffering from asthma is expected to increase by more than 100 million by 2025. North America is expected to dominate the respiratory devices market, owing to increasing number of hospitalizations and emergency visits associated with acute or life threatening medical problems. According to the study by Society of Critical Care Medicine 2016, more than 5.7 million patients are admitted annually to intensive care units (ICUs) in the U.S. for support of airway, breathing or circulation, and comprehensive management of injury. Also, According to the Centers of Disease Control and Prevention (CDC), 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were registered in the U.S. hospital facilities. However, stringent FDA approvals, lack of awareness about innovative devices and unaffordable or high cost of respiratory devices are the factors restraining growth of the respiratory devices market.

Increasing support from international organizations for prevention of chronic respiratory diseases is expected to accelerate the market growth

Various organizations, institutions, and agencies are working towards improving the diagnosis and the medical care needed to reduce the global burden of respiratory diseases. For instance, the Global Alliance against Chronic Respiratory Diseases (GARD) was formed with the support from the World Health Organization (WHO) to control chronic respiratory diseases. GARD is a voluntary alliance of national, international organizations, and agencies from many economies. The main objective of GARD is to develop simple and affordable strategies for chronic respiratory diseases (CRD) and to encourage economies to implement health promotion and CRD prevention policies. Also, increasing birth defects such as newborn respiratory distress syndrome, cyanosis, and Broncho-pulmonary dysplasia requires the need for neonate/pediatric respiratory devices to increase the survival chances of infants. According to the Centers of Disease Control and Prevention (CDC), an estimate of 1.5 million babies were born with birth defects with about one quarter primary consultations related to respiratory complaints.

The major players operating the global respiratory devices market include Koninklijke Philips N.V., 3M, AstraZeneca Plc., GE Healthcare, GlaxoSmithKline Plc., Medtronic plc, Becton, Dickinson and Company, Invacare Corporation, ResMed, Inc., and CareFusion Corporation.

Respiratory devices or equipment are commonly used in the medical settings as per the medical condition. Ventilators are the most common tools, which are commonly used in emergency medicine and long-term critical care. In addition to the therapeutic respiratory devices, the diagnostic and monitoring devices minimize hospitalizations, thereby lowering the cost associated with medical settings. 

Market Dynamics

The major factor driving growth of the respiratory devices market include INCREASING prevalence of respiratory diseases such as COPD and asthma, increasing respiratory disease with rise in pollution level and rising geriatric population. According to the study by Global Burden of Disease, 2016, an estimated around 251 million cases of COPD were reported worldwide. According to the World Health Organization (WHO), 2015, an estimated 3.17 million deaths were caused by the disease accounting for 5% of all deaths. However, lack of awareness regarding the diseases harmful effects of certain respiratory care devices on neonates are the factors restraining respiratory devices market growth.

Key features of the study:

  • This report provides in-depth analysis of respiratory devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global respiratory devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Koninklijke Philips N.V., 3M, AstraZeneca Plc., GE Healthcare, GlaxoSmithKline Plc., Medtronic, Becton, Dickinson and Company, Invacare Corporation, ResMed, Inc., and CareFusion Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global respiratory devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the respiratory device market

Detailed Segmentation:

  • Global Respiratory Devices Market, By Product Type:
    • Therapeutic Devices
      • Positive Airway Pressure (PAP) Devices
        • Continuous PAP Devices
        • Automatic PAP Devices
        • Bi-level PAP Devices
      • Inhalers
        • Metered Dose Inhalers
        • Dry Powder Inhalers
        • Nebulizers
      • Humidifiers
        • Heated Humidifiers
        • Passover Humidifiers
      • Oxygen Concentrators
        • Fixed Oxygen Concentrators
        • Portable oxygen Concentrators
      • Reusable Resuscitators
      • Respiratory masks
      • Ventilators
      • Nitric Oxide Delivery Units
      • Others
    • Monitoring Devices
      • Pulse Oximeters
      • Capnographs
      • Gas Analyzers
    • Diagnostic Devices
      • Spirometer
      • Peak Flow Meters
      • Polysomnography Devices
      • Others
  • Global Respiratory Devices Market, By Age Group:
    • Neonatal/Pediatric
    • Adults
  • Global Respiratory Devices Market, By Application:
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Sleep Apnea
    • Asthma
    • Others
  • Global Respiratory Devices Market, By End User:
    • Hospitals
    • Clinics
    • Home Care Settings
    • Ambulatory Care Centers
  • Global Respiratory Devices Market, By Geography:
    • North America
      • By Product Type:
        • Therapeutic Devices:
          • Positive Airway Pressure (PAP) Devices
            • Continuous PAP Devices
            • Automatic PAP Devices
            • Bi-level PAP Devices
          • Inhalers
            • Metered Dose Inhalers
            • Dry Powder Inhalers
            • Nebulizers
          • Humidifiers
            • Heated Humidifiers
            • Passover Humidifiers
          • Oxygen Concentrators
            • Fixed Oxygen Concentrators
            • Portable Oxygen Concentrators
          • Reusable Resuscitators
          • Respiratory Masks
          • Ventilators
          • Nitric Oxide Delivery Units
        • Diagnostic Devices:
          • Spirometers
          • Peak Flow Meters
          • Polysomnography Devices
          • Others
        • Monitoring Devices:
          • Pulse Oximeters
          • Capnographs
          • Gas Analyzers
        • Consumables and Accessories:
          • Disposable Masks
          • Disposable Resuscitators
          • Tracheostomy Tubes
          • Nasal Cannulas
          • Others
      • By Age Group:
        • Neonatal/Pediatric
        • Adults
      • By Application:
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Sleep Apnea
        • Asthma
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Therapeutic Devices:
          • Positive Airway Pressure (PAP) Devices
            • Continuous PAP Devices
            • Automatic PAP Devices
            • Bi-level PAP Devices
          • Inhalers
            • Metered Dose Inhalers
            • Dry Powder Inhalers
            • Nebulizers
          • Humidifiers
            • Heated Humidifiers
            • Passover Humidifiers
          • Oxygen Concentrators
            • Fixed Oxygen Concentrators
            • Portable Oxygen Concentrators
          • Reusable Resuscitators
          • Respiratory Masks
          • Ventilators
          • Nitric Oxide Delivery Units
        • Diagnostic Devices:
          • Spirometers
          • Peak Flow Meters
          • Polysomnography Devices
          • Others
        • Monitoring Devices:
          • Pulse Oximeters
          • Capnographs
          • Gas Analyzers
        • Consumables and Accessories:
          • Disposable Masks
          • Disposable Resuscitators
          • Tracheostomy Tubes
          • Nasal Cannulas
          • Others
      • By Age Group:
        • Neonatal/Pediatric
        • Adults
      • By Application:
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Sleep Apnea
        • Asthma
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Therapeutic Devices:
          • Positive Airway Pressure (PAP) Devices
            • Continuous PAP Devices
            • Automatic PAP Devices
            • Bi-level PAP Devices
          • Inhalers
            • Metered Dose Inhalers
            • Dry Powder Inhalers
            • Nebulizers
          • Humidifiers
            • Heated Humidifiers
            • Passover Humidifiers
          • Oxygen Concentrators
            • Fixed Oxygen Concentrators
            • Portable Oxygen Concentrators
          • Reusable Resuscitators
          • Respiratory Masks
          • Ventilators
          • Nitric Oxide Delivery Units
        • Diagnostic Devices:
          • Spirometers
          • Peak Flow Meters
          • Polysomnography Devices
          • Others
        • Monitoring Devices:
          • Pulse Oximeters
          • Capnographs
          • Gas Analyzers
        • Consumables and Accessories:
          • Disposable Masks
          • Disposable Resuscitators
          • Tracheostomy Tubes
          • Nasal Cannulas
          • Others
      • By Age Group:
        • Neonatal/Pediatric
        • Adults
      • By Application:
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Sleep Apnea
        • Asthma
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Therapeutic Devices:
          • Positive Airway Pressure (PAP) Devices
            • Continuous PAP Devices
            • Automatic PAP Devices
            • Bi-level PAP Devices
          • Inhalers
            • Metered Dose Inhalers
            • Dry Powder Inhalers
            • Nebulizers
          • Humidifiers
            • Heated Humidifiers
            • Passover Humidifiers
          • Oxygen Concentrators
            • Fixed Oxygen Concentrators
            • Portable Oxygen Concentrators
          • Reusable Resuscitators
          • Respiratory Masks
          • Ventilators
          • Nitric Oxide Delivery Units
        • Diagnostic Devices:
          • Spirometers
          • Peak Flow Meters
          • Polysomnography Devices
          • Others
        • Monitoring Devices:
          • Pulse Oximeters
          • Capnographs
          • Gas Analyzers
        • Consumables and Accessories:
          • Disposable Masks
          • Disposable Resuscitators
          • Tracheostomy Tubes
          • Nasal Cannulas
          • Others
      • By Age Group:
        • Neonatal/Pediatric
        • Adults
      • By Application:
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Sleep Apnea
        • Asthma
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Therapeutic Devices:
          • Positive Airway Pressure (PAP) Devices
            • Continuous PAP Devices
            • Automatic PAP Devices
            • Bi-level PAP Devices
          • Inhalers
            • Metered Dose Inhalers
            • Dry Powder Inhalers
            • Nebulizers
          • Humidifiers
            • Heated Humidifiers
            • Passover Humidifiers
          • Oxygen Concentrators
            • Fixed Oxygen Concentrators
            • Portable Oxygen Concentrators
          • Reusable Resuscitators
          • Respiratory Masks
          • Ventilators
          • Nitric Oxide Delivery Units
        • Diagnostic Devices:
          • Spirometers
          • Peak Flow Meters
          • Polysomnography Devices
          • Others
        • Monitoring Devices:
          • Pulse Oximeters
          • Capnographs
          • Gas Analyzers
        • Consumables and Accessories:
          • Disposable Masks
          • Disposable Resuscitators
          • Tracheostomy Tubes
          • Nasal Cannulas
          • Others
      • By Age Group:
        • Neonatal/Pediatric
        • Adults
      • By Application:
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Sleep Apnea
        • Asthma
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Therapeutic Devices:
          • Positive Airway Pressure (PAP) Devices
            • Continuous PAP Devices
            • Automatic PAP Devices
            • Bi-level PAP Devices
          • Inhalers
            • Metered Dose Inhalers
            • Dry Powder Inhalers
            • Nebulizers
          • Humidifiers
            • Heated Humidifiers
            • Passover Humidifiers
          • Oxygen Concentrators
            • Fixed Oxygen Concentrators
            • Portable Oxygen Concentrators
          • Reusable Resuscitators
          • Respiratory Masks
          • Ventilators
          • Nitric Oxide Delivery Units
        • Diagnostic Devices:
          • Spirometers
          • Peak Flow Meters
          • Polysomnography Devices
          • Others
        • Monitoring Devices:
          • Pulse Oximeters
          • Capnographs
          • Gas Analyzers
        • Consumables and Accessories:
          • Disposable Masks
          • Disposable Resuscitators
          • Tracheostomy Tubes
          • Nasal Cannulas
          • Others
      • By Age Group:
        • Neonatal/Pediatric
        • Adults
      • By Application:
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Sleep Apnea
        • Asthma
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Koninklijke Philips N.V. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • 3M
    • AstraZeneca Plc.
    • GE Healthcare
    • GlaxoSmithKline Plc.
    • Medtronic
    • Becton, Dickinson and Company
    • Invacare Corporation
    • ResMed, inc.
    • CareFusion Corporation

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Age Group
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Highlights
    • Regulatory Scenario
    • Reimbursement Scenario
    • FDA Approvals
    • Epidemiology
  4. Global Respiratory Devices Market, By Product Type, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 – 2025
      • Segment Trends
    • Therapeutic Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
      • Segment Trends
        • Positive Airway Pressure (PAP) Devices
          • Continuous PAP Devices
          • Automatic PAP Devices
          • Bi-level PAP Devices
        • Inhalers
          • Metered Dose Inhalers
          • Dry Powder Inhalers
          • Nebulizers
        • Humidifiers
          • Heated Humidifiers
          • Passover Humidifiers
        • Oxygen Concentrators
          • Fixed Oxygen Concentrators
          • Portable Oxygen Concentrators
        • Reusable Resuscitators
        • Respiratory Masks
        • Ventilators
        • Nitric Oxide Delivery Units
        • Others
    • Monitoring Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
      • Segment Trends
        • Pulse Oximeters
        • Capnographs
        • Gas Analyzers
    • Diagnostic Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
      • Segment Trends
        • Spirometer
        • Peak Flow Meters
        • Polysomnography Devices
        • Others
    • Consumables and Accessories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
      • Segment Trends
        • Disposable Masks
        • Disposable Resuscitators
        • Tracheostomy Tubes
        • Nasal Cannulas
        • Others
  5. Global Respiratory Devices Market, By Age Group, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 – 2025
      • Segment Trends
    • Neonatal/ Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
  6. Global Respiratory Devices Market, By Application, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 – 2025
      • Segment Trends
    • Chronic Obstructive Pulmonary Disease (COPD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Sleep Apnea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Asthma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
  7. Global Respiratory Devices Market, By End User, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 – 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Ambulatory Care Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
  8. Global Respiratory Devices Market, By Region, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 – 2025
    • North America
      • Market Size and Forecast, By Product Type, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Age Group, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Age Group, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Age Group, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Age Group, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Age Group, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Age Group, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Koninklijke Philips N.V.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • 3M
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • AstraZeneca Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • GE Healthcare
        •  Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • GlaxoSmithKline Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Invacare Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • ResMed, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • CareFusion Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 52 figures on "Respiratory Devices Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.